Advertisement

International Journal of Clinical Pharmacy

, Volume 34, Issue 6, pp 855–862 | Cite as

Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria

  • Mohd Shahezwan Abd WahabEmail author
  • Karin Nyfort-Hansen
  • Stefan R. Kowalski
Research Article

Abstract

Background The elderly population is increasing worldwide. Due to age-related physiological changes that affect the pharmacokinetics and pharmacodynamics of drugs, the elderly are predisposed to adverse drug reactions. Prescribing of potentially inappropriate medications (PIMs) has been found to be prevalent among the elderly and PIM use has been associated with hospitalisations and mortality. Objectives This study aims to identify the prevalence and nature of pre-admission inappropriate prescribing by using the STOPP (screening tool of older people’s prescriptions) criteria amongst a sample of hospitalised elderly inpatients in South Australia. Setting Medical, surgical and rehabilitation wards of a public teaching hospital in Adelaide, South Australia. Main outcome measure Pre-admission prevalence of PIM. Method Medication management plans of 100 patients of ≥65 years old were prospectively studied to determine the prevalence of pre-admission PIM use. Sixty-five criteria of STOPP were applied to identify PIMs. Results The total number of pre-admission medications screened during the study period was 949; the median number of medicines per patient was nine (range 2–28). Overall the STOPP criteria identified 138 PIMs in 60 % of patients. The most frequently encountered PIM was opiates prescribed in patients with recurrent falls (12.3 %), followed by benzodiazepines in fallers (10.1 %) and proton pump inhibitors when prescribed for peptic ulcer disease for long-term at maximum doses (9.4 %). The number of medications were found to have a positive correlation with pre-admission PIM use (rs = 0.49, P < 0.01). Conclusions Pre-admission PIM use is highly prevalent among the studied population. Strategies to reduce PIM use should be undertaken by physicians and pharmacists. The use of the STOPP criteria in clinical practice to reduce prescriptions of inappropriate medications requires further investigation.

Keywords

Australia Elderly Potentially inappropriate prescribing (PIP) Potentially inappropriate medicines (PIM) Screening tool of older person’s prescriptions (STOPP) 

Notes

Funding

None.

Conflicts of interest

No conflicts of interest to declare.

References

  1. 1.
    Department of Economic and Social Affairs, Population Division. World population ageing, 1950–2050. New York: United Nations; 2002. http://www.un.org/esa/population/publications/worldageing19502050/. Accessed 6 June 2012.
  2. 2.
    Australian Bureau of Statistics. Population by age and sex, Australian States and territories, June 2010. Belconnen, ACT: Australian Bureau of Statistics; 2010. http://www.abs.gov.au/Ausstats/abs@.nsf/mf/3201.0. Accessed 5 June 2012.
  3. 3.
    Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46–54.PubMedCrossRefGoogle Scholar
  4. 4.
    Willlams CM. Using medications appropriately in older adults. Am Fam Physician. 2002;66(10):1917–24.PubMedGoogle Scholar
  5. 5.
    O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138–41.PubMedCrossRefGoogle Scholar
  6. 6.
    Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash). 2002;42(6):847–57.Google Scholar
  7. 7.
    Pattanaworasate W, Emmerton L, Pulver L, Winckel K. Comparison of prescribing criteria in hospitalised Australian elderly. Pharmacy Pract (Internet). 2010;8(2):132–8.Google Scholar
  8. 8.
    Widagdo IS, Nyfort-Hansen K, Kowalski SR. Prevalence of potentially inappropriate medication use in elderly hospitalised patients. J Pharm Prac Res. 2011;41(2):122–5.Google Scholar
  9. 9.
    McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156(3):385–91.PubMedGoogle Scholar
  10. 10.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825–32.PubMedCrossRefGoogle Scholar
  11. 11.
    Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45(8):945–8.PubMedGoogle Scholar
  12. 12.
    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.PubMedCrossRefGoogle Scholar
  14. 14.
    The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.CrossRefGoogle Scholar
  15. 15.
    Ryan C, O’Mahony D, Kennedy J, Weedle P, Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68(6):936–47.PubMedCrossRefGoogle Scholar
  16. 16.
    Laroche ML, Charmes JP, Bouthier F, Merle L. Inappropriate medications in the elderly. Clin Pharmacol Ther. 2009;85(1):94–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.PubMedGoogle Scholar
  19. 19.
    Curtis LH, Østbye T, Sendersky V, Hutchison S, Dans PE, Wright AV, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med. 2004;164(15):1621–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother. 2006;4(2):134–43.PubMedCrossRefGoogle Scholar
  21. 21.
    Lau DT, Kasper JD, Potter DE, Lyles A. Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res. 2004;39(5):1257–76.PubMedCrossRefGoogle Scholar
  22. 22.
    Sloane PD, Zimmerman S, Brown LC, Ives TJ, Walsh JF. Inappropriate medication prescribing in residential care/assisted living facilities. J Am Geriatr Soc. 2002;50(6):1001–11.PubMedCrossRefGoogle Scholar
  23. 23.
    Chetty R, Gray A. Inappropriate prescribing in an elderly population: findings from a South African public sector survey. Int J Phar Pract. 2004;12(3):149–54.CrossRefGoogle Scholar
  24. 24.
    Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing. 2009;38(5):603–606.Google Scholar
  25. 25.
    Rossi S. Australian medicines handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2009. (ISBN 978–097-5791–99-8).Google Scholar
  26. 26.
    Cooper JK. Drug treatment of Alzheimer’s disease. Arch Intern Med. 1991;151(2):245–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Tinetti ME. Preventing falls in elderly persons. N Engl J Med. 2003;348(1):42–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther. 2011;36(1):33–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164(3):305–12.PubMedCrossRefGoogle Scholar
  30. 30.
    Egger SS, Bachmann A, Hubmann N, Schlienger RG, Krähenbühl S. Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging. 2006;23(10):823–37.PubMedCrossRefGoogle Scholar
  31. 31.
    Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med. 2000;160(18):2825–31.PubMedCrossRefGoogle Scholar
  32. 32.
    Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med. 2002;162(15):1707–12.PubMedCrossRefGoogle Scholar
  33. 33.
    Howard M, Dolovich L, Kaczorowski J, Sellors C, Sellors J. Prescribing of potentially inappropriate medications to elderly people. Fam Pract. 2004;21(3):244–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc. 2004;79(1):122–39.PubMedCrossRefGoogle Scholar
  35. 35.
    Avorn J. Improving drug use in elderly patients: getting to the next level. JAMA. 2001;286(22):2866–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR, et al. What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging. 2008;25(8):693–706.PubMedCrossRefGoogle Scholar
  37. 37.
    Australian Prescriber. Top 10 drugs. Deakin, ACT: Australian Prescriber; 2010. http://www.australianprescriber.com/magazine/33/6/artid/1149. Accessed 6 June 2012.
  38. 38.
    Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122(10):896–903.PubMedCrossRefGoogle Scholar
  39. 39.
    Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947–53.PubMedCrossRefGoogle Scholar
  40. 40.
    Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165(1):68–74.PubMedCrossRefGoogle Scholar
  41. 41.
    Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005;22(1):69–82.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Mohd Shahezwan Abd Wahab
    • 1
    Email author
  • Karin Nyfort-Hansen
    • 2
  • Stefan R. Kowalski
    • 3
  1. 1.Faculty of PharmacyUniversiti Teknologi MARAPuncak AlamMalaysia
  2. 2.Repatriation General HospitalAdelaideAustralia
  3. 3.School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia

Personalised recommendations